Showing results (181-190 of 472) with videos related to
Sort By:
Pageof 48
Nano Letters|September 29, 2007
Amine-gold linked single-molecule circuits: experiment and theorySu Ying Quek, Latha Venkataraman, Hyoung Joon Choi, et al.Plos Medicine|March 23, 2019
Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscapePatrick P J Phillips, Carole D Mitnick, James D Neaton, et al.JAMA|April 23, 1997
End-stage renal disease in African-American and white men. 16-year MRFIT findingsM J Klag, P K Whelton, B L Randall, et al.Nano Letters|February 5, 2014
Tunable charge transport in single-molecule junctions via electrolytic gatingBrian Capozzi, Qishui Chen, Pierre Darancet, et al.Nano Letters|January 23, 2014
Determination of energy level alignment and coupling strength in 4,4'-bipyridine single-molecule junctionsTaekyeong Kim, Pierre Darancet, Jonathan R Widawsky, et al.Genes|January 25, 2025
Identifying Genetic Predisposition to Dozer Lamb Syndrome: A Semi-Lethal Muscle Weakness Disease in SheepMorgan R Stegemiller, Margaret A Highland, Kathleen M Ewert, et al.Journal of the American Chemical Society|October 6, 2017
Electronically Transparent Au-N Bonds for Molecular JunctionsYaping Zang, Andrew Pinkard, Zhen-Fei Liu, et al.Preventive Medicine|September 1, 1991
Cigarette smoking and mortality. MRFIT Research GroupL H Kuller, J K Ockene, E Meilahn, et al.JAMA|December 24, 1997
Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention TrialF L Brancati, P K Whelton, B L Randall, et al.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1995
Insights from monitoring the CPCRA didanosine/zalcitabine trial. Terry Beirn Community Programs for Clinical Research on AIDST R Fleming, J D Neaton, A Goldman, et al.Pageof 48